ASTRO announces 2010 Annual Meeting awards

September 22, 2010

The American Society for Radiation Oncology (ASTRO) is pleased to announce the recipients of several Annual Meeting awards. Recipients will receive their honors during ASTRO's 52nd Annual Meeting in San Diego, being held October 31-November 4, 2010.

"It is my pleasure to congratulate each of these talented individuals whose science will be honored this year," Anthony L. Zietman, M.D., ASTRO president and a radiation oncologist at Massachusetts General Hospital in Boston, said. "The high quality of the research submitted for this year's Annual Meeting has raised the bar for future Annual Meetings. It is a privilege to recognize these researchers for their impressive work."

The Resident Clinical/Basic Science Research Award is designed to promote clinical research by young scientists. It is granted to the top three resident-authors of significant abstracts in physics, biology and clinical practice.

Resident Clinical/Basic Science Research AwardThe Resident Poster Viewing Award recognizes the top resident poster presentations in each of the poster categories - clinical, radiation and cancer biology and radiation physics.

Resident Poster Viewing - ClinicalResident Poster Viewing - Radiation and Cancer Biology Resident Poster Viewing - Radiation PhysicsThe Resident Digital Poster Discussion Award is given to the top three abstracts in clinical, radiation physics, and radiation and cancer biology. Resident Digital Poster DiscussionThe Basic Science Abstract Award is designed to encourage participation in the ASTRO Annual Meeting by basic scientists with an accepted abstract in either the biology or physics category.

Basic Science Scientific Abstract Award Annual Meeting Scientific Abstract Awards are given to researchers with accepted abstracts who meet certain criteria. Annual Meeting Scientific Abstract Award
-end-
For more information about ASTRO's 52nd Annual Meeting in San Diego, visit www.astro.org/Meetings/AnnualMeetings.

ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy. For more information on radiation therapy, visit www.rtanswers.org. To learn more about ASTRO, visit www.astro.org.

American Society for Radiation Oncology

Related Radiation Articles from Brightsurf:

Sheer protection from electromagnetic radiation
A printable ink that is both conductive and transparent can also block radio waves.

What membrane can do in dealing with radiation
USTC recently found that polymethylmethacrylate (PMMA) and polyvinyl chloride (PVC) can release acidic substance under γ radiation, whose amount is proportional to the radiation intensity.

First measurements of radiation levels on the moon
In the current issue (25 September) of the prestigious journal Science Advances, Chinese and German scientists report for the first time on time-resolved measurements of the radiation on the moon.

New biomaterial could shield against harmful radiation
Northwestern University researchers have synthesized a new form of melanin enriched with selenium.

A new way to monitor cancer radiation therapy doses
More than half of all cancer patients undergo radiation therapy and the dose is critical.

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
Oncotarget Volume 11, Issue 4: In this study, locally advanced head and neck cancer patients undergoing definitive chemoradiation were randomly allocated to weekly cisplatin - radiation {CRT arm} or nimotuzumab -weekly cisplatin -radiation {NCRT arm}.

Breaking up amino acids with radiation
A new experimental and theoretical study published in EPJ D has shown how the ions formed when electrons collide with one amino acid, glutamine, differ according to the energy of the colliding electrons.

Radiation breaks connections in the brain
One of the potentially life-altering side effects that patients experience after cranial radiotherapy for brain cancer is cognitive impairment.

Fragmenting ions and radiation sensitizers
The anti-cancer drug 5-fluorouracil (5FU) acts as a radiosensitizer: it is rapidly taken up into the DNA of cancer cells, making the cells more sensitive to radiotherapy.

'Seeing the light' behind radiation therapy
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime.

Read More: Radiation News and Radiation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.